In UKB the mean duration between the primary visit (blood draw date) and death is currently 9.2 years (± 3.8) and suggests that WES screening for CHIP variants may be used as a precision health tool to contribute to earlier cancer detection by assessing individuals with higher susceptibility risks. Here, STUB1 is linked to cancer.